U.K. Preclinical Cro Market Size & Outlook, 2026-2033

Name: U.K. Preclinical Cro Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The preclinical cro market in the UK is expected to reach a projected revenue of US$ 1,027.9 million by 2033. A compound annual growth rate of 9.2% is expected of the UK preclinical cro market from 2026 to 2033.

UK preclinical cro development stage outlook (Revenue, USD million, 2021-2033)
- Target Discovery
  - Target Identification & Validation
  - Functional Genomics (CRISPR, RNAi)
  - Omics Platforms
  - High-Throughput Screening (HTS)
  - Fragment-Based Screening
  - In Silico / AI-Driven Drug Design
  - Others
- Preclinical Optimization, Efficacy & PK/PD
  - In Vitro Pharmacology
  - In Vivo Efficacy Models
  - PK/PD Studies
  - ADME (Including CYP/Transporter Assays)
  - Exploratory / Non-GLP Toxicology
  - Rare Disease Models
  - Biomarker Validation
  - Others
- IND-Enabling Safety (GLP)
  - General Toxicology
  - Safety Pharmacology
  - Reproductive & Developmental Toxicology
  - Juvenile Toxicology
  - Genetic Toxicology
  - Carcinogenicity Studies
  - Others
- Bioanalysis & Analytics
  - LC-MS/MS Bioanalysis
  - Ligand-Binding Assays (LBA)
  - Immunogenicity Testing
  - Product Analysis / ICH Methods
  - Stability Testing
  - Biomarker Quantification
  - Others
- Early CMC / Phase I–II Supply
  - Formulation Development
  - GMP Manufacturing & Packaging
  - Clinical Supply Logistics
  - Others
UK preclinical cro indication outlook (Revenue, USD million, 2021-2033)
- Oncology
- CNS
- Infectious Diseases
- Cardiovascular Diseases
- Metabolic Disorders
- Rare Diseases
- Others
UK preclinical cro end use outlook (Revenue, USD million, 2021-2033)
- Pharmaceutical and Biopharmaceutical Companies
- Medical Device Companies
- Academic and Research Institutes
- Others

U.K. Preclinical Cro Market Size & Outlook, 2026-2033

Sign up - it's easy, and free!